Clover Health Investments (CLOV) Stock: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.36
0.13 (2.96%)
▲
5d:
-3.01%
30d:
+1.28%
90d:
-13.93%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CLOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.36, which is considered fair relative to its 30-day fair value range of $4.19 to $4.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.2) compared to its historical average (35.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $4.11, while resistance sits at $4.69.
Market Sentiment: CLOV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.38 (+27.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $4.11, while resistance sits at $4.69.
Market Sentiment: CLOV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.38 (+27.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.19 -
$4.64
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.1% below Wall St target ($5.38)
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$4.19 -
$4.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.11
Resistance Level
$4.69
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.20
Wall Street Target
$5.38
(+27.1%)
Revenue Growth (YoY)
55.6%
Profit Margin
-0.7%
Valuation Discount vs History
-7.3% cheaper
PE vs Historical
28.2 vs 35.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.3%
(market-implied from PE analysis)
1-Year Target
$3.92
(-7%)
2-Year Target
$3.63
(-14%)
3-Year Target
$3.37
(-20%)
3-Yr Target (if PE normalizes)
(PE: 28→35)
$4.23
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.2, Growth: 7.1%)
$5.20
(+23%)
Base:
(SPY PE: 20.4, Growth: 7.1%)
$3.76
(-11%)
Bear:
(PE: 17.3, Growth: 7.1%)
$3.20
(-24%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.2 to 35.4
Stabilization Target:
$5.31
(+25.5%)
PE Expansion Potential:
+25.5%
Share & Embed Analysis
Last updated: October 02, 2026 2:36 PM ET
Data refreshes hourly during market hours. Next update: 3:36 PM
Data refreshes hourly during market hours. Next update: 3:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 66 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$482 | 56 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$451 | 45 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$424 | 65 BUY |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
